HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 617 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $11,545 | -99.8% | 101,451 | -2.0% | 3.09% | +65.5% |
Q3 2022 | $6,405,000 | -23.7% | 103,485 | -1.6% | 1.87% | -20.2% |
Q2 2022 | $8,389,000 | -23.6% | 105,175 | +0.8% | 2.34% | -7.8% |
Q1 2022 | $10,981,000 | -2.1% | 104,370 | +0.3% | 2.54% | +3.9% |
Q4 2021 | $11,214,000 | -1.6% | 104,063 | +0.0% | 2.44% | -10.4% |
Q3 2021 | $11,396,000 | +10.8% | 104,034 | -5.3% | 2.73% | +13.2% |
Q2 2021 | $10,282,000 | -1.1% | 109,799 | -2.8% | 2.41% | -7.9% |
Q1 2021 | $10,401,000 | +26.4% | 113,009 | +0.5% | 2.62% | +14.7% |
Q4 2020 | $8,229,000 | -10.2% | 112,495 | -4.7% | 2.28% | -19.5% |
Q3 2020 | $9,168,000 | +32.3% | 118,027 | -5.3% | 2.84% | +23.2% |
Q2 2020 | $6,930,000 | +77.6% | 124,693 | -5.3% | 2.30% | +43.2% |
Q1 2020 | $3,902,000 | -18.7% | 131,738 | -0.6% | 1.61% | +9.6% |
Q4 2019 | $4,798,000 | +35.2% | 132,548 | +1.7% | 1.47% | +26.1% |
Q3 2019 | $3,549,000 | +14.3% | 130,335 | +0.9% | 1.16% | +15.1% |
Q2 2019 | $3,106,000 | – | 129,110 | – | 1.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |